BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22206779)

  • 21. Signal transducer and activator of transcription gain-of-function primary immunodeficiency/immunodysregulation disorders.
    Consonni F; Dotta L; Todaro F; Vairo D; Badolato R
    Curr Opin Pediatr; 2017 Dec; 29(6):711-717. PubMed ID: 28914637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
    Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
    J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematopoietic cell transplantation for correction of primary immunodeficiencies.
    Filipovich A
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S49-S52. PubMed ID: 18724301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary immunodeficiencies: milestones in the history of pediatric immunology.
    Burgio GR; Notarangelo LD; Duse M; Ugazio AG
    Pediatr Hematol Oncol; 1991; 8(3):203-14. PubMed ID: 1742178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stem cell transplantation in primary immunodeficiencies.
    Notarangelo LD; Forino C; Mazzolari E
    Curr Opin Allergy Clin Immunol; 2006 Dec; 6(6):443-8. PubMed ID: 17088649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Age-related changes in BAFF and APRIL profiles and upregulation of BAFF and APRIL expression in patients with primary antibody deficiency.
    Jin R; Kaneko H; Suzuki H; Arai T; Teramoto T; Fukao T; Kondo N
    Int J Mol Med; 2008 Feb; 21(2):233-8. PubMed ID: 18204790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DOCK8 deficiency: Insights into pathophysiology, clinical features and management.
    Biggs CM; Keles S; Chatila TA
    Clin Immunol; 2017 Aug; 181():75-82. PubMed ID: 28625885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The syndrome of hemophagocytic lymphohistiocytosis in primary immunodeficiencies: implications for differential diagnosis and pathogenesis.
    Bode SF; Ammann S; Al-Herz W; Bataneant M; Dvorak CC; Gehring S; Gennery A; Gilmour KC; Gonzalez-Granado LI; Groß-Wieltsch U; Ifversen M; Lingman-Framme J; Matthes-Martin S; Mesters R; Meyts I; van Montfrans JM; Pachlopnik Schmid J; Pai SY; Soler-Palacin P; Schuermann U; Schuster V; Seidel MG; Speckmann C; Stepensky P; Sykora KW; Tesi B; Vraetz T; Waruiru C; Bryceson YT; Moshous D; Lehmberg K; Jordan MB; Ehl S;
    Haematologica; 2015 Jul; 100(7):978-88. PubMed ID: 26022711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unravelling the association of partial T-cell immunodeficiency and immune dysregulation.
    Liston A; Enders A; Siggs OM
    Nat Rev Immunol; 2008 Jul; 8(7):545-58. PubMed ID: 18551129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on the treatment of primary immunodeficiencies.
    García JM; Español T; Gurbindo MD; Casas C C
    Allergol Immunopathol (Madr); 2007; 35(5):184-92. PubMed ID: 17923072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What has happened in the last 50 years in immunology.
    Wong M
    J Paediatr Child Health; 2015 Feb; 51(2):135-9. PubMed ID: 25677480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune deficiency and autoimmunity.
    Atkinson TP
    Curr Opin Rheumatol; 2012 Sep; 24(5):515-21. PubMed ID: 22820513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Molecular genetics of X-linked primary immunodeficiencies: advances in diagnosis and prevention].
    Carbonara A; Brusco A; Carbonara C
    Ann Ital Med Int; 1996; 11(3):180-6. PubMed ID: 8998263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical considerations in the hematopoietic stem cell transplant management of primary immunodeficiencies.
    Laberko A; Gennery AR
    Expert Rev Clin Immunol; 2018 Apr; 14(4):297-306. PubMed ID: 29589971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary immunodeficiencies (PIDs) presenting with cytopenias.
    Notarangelo LD
    Hematology Am Soc Hematol Educ Program; 2009; ():139-43. PubMed ID: 20008192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cellular immunodeficiencies.
    Buckley RH
    J Allergy Clin Immunol; 2002 May; 109(5):747-57. PubMed ID: 11994695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene therapy for primary immunodeficiencies: Part 1.
    Cavazzana-Calvo M; Fischer A; Hacein-Bey-Abina S; Aiuti A
    Curr Opin Immunol; 2012 Oct; 24(5):580-4. PubMed ID: 22981681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Gene therapy for hereditary immunodeficiencies].
    Fischer A; de Saint-Basile G; Disanto JP; Hacein-Bey S; Sharara L; Cavazzana-Calvo M
    C R Seances Soc Biol Fil; 1996; 190(1):77-93. PubMed ID: 8881271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene therapy for primary immunodeficiencies.
    Kildebeck E; Checketts J; Porteus M
    Curr Opin Pediatr; 2012 Dec; 24(6):731-8. PubMed ID: 23073463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in basic and clinical immunology.
    Chinen J; Finkelman F; Shearer WT
    J Allergy Clin Immunol; 2006 Aug; 118(2):489-95. PubMed ID: 16890776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.